| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2006 | CN1263397C High-calory liquid oral supplement |
| 07/12/2006 | CA2489780A1 Methods for preventing or treating a condition or a disease associated with angiogenesis |
| 07/11/2006 | US7074983 Trangenic cell for use in human therapeutics and diagnostics |
| 07/11/2006 | US7074915 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 07/11/2006 | US7074913 Receptor for B anthracis toxin |
| 07/11/2006 | US7074910 PRO4340 nucleic acids |
| 07/11/2006 | US7074909 Prevent, therapy of disease; isolated nucleic acid which codes antibody; binding to human antigen |
| 07/11/2006 | US7074905 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2006 | US7074904 MHC molecule that contains a peptide-binding groove, and a presenting peptide covalently linked to the MHC molecule, the fusion complex being capable of modulating the activity of a T cell. |
| 07/11/2006 | US7074901 Nucleotide sequences coding polypeptides for use in the tumor/cancer therapy |
| 07/11/2006 | US7074900 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
| 07/11/2006 | US7074898 Polypeptide for use as an antiproliferative agent in the treatment of cell proliferative disorders |
| 07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
| 07/11/2006 | US7074895 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/11/2006 | US7074893 Alzheimer's disease |
| 07/11/2006 | US7074892 Thrombin generation inhibitors |
| 07/11/2006 | US7074891 Stimulant releasing of archidonic acid from target cells; polypeptides; induction gene expression |
| 07/11/2006 | US7074890 Process for preparing glycopeptide phosphonate derivatives |
| 07/11/2006 | US7074889 Identification of a new cytotoxic activity from the ink of Aplysia punctata |
| 07/11/2006 | US7074888 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
| 07/11/2006 | US7074883 Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content |
| 07/11/2006 | US7074786 Histogranin-like peptides, processes for their preparation and uses thereof |
| 07/11/2006 | US7074775 Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| 07/11/2006 | US7074772 Expression vector for use in the transfer of genetic information |
| 07/11/2006 | US7074768 Modified protein kinase A-specific oligonucleotides and methods of their use |
| 07/11/2006 | US7074767 Preparation of a therapeutic composition |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074765 Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 07/11/2006 | US7074764 Treatment of intestinal epithelial cell malfunction, inflammation or damage with Hepatocyte growth factor |
| 07/11/2006 | US7074763 Stable formulations of nerve growth factor |
| 07/11/2006 | US7074762 Contacting metanephric tissue with a growth factor-containing formulation comprising one or more growth factors for metanephric development for therapy of metanephric tissue that is transplanted into a recipient |
| 07/11/2006 | US7074761 Drug for hormone-sensitive tumors; glandular disorders; antiulcer agents; sleep disorders; gene therapy; Alzheimer's disease; genetic engineered polypeptide |
| 07/11/2006 | US7074760 Bactericides; peptide antibiotics |
| 07/11/2006 | US7074759 Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced |
| 07/11/2006 | US7074758 Two gonadotropin releasing hormones and a method to isolate the same |
| 07/11/2006 | US7074756 Liver generation promoter |
| 07/11/2006 | US7074755 Immobilization of erythropoietin; increase reticulocyte production in bone marrow; anemia therapy |
| 07/11/2006 | US7074620 Controlling protein levels in eucaryotic organisms |
| 07/11/2006 | US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells |
| 07/11/2006 | US7074616 Aids screening using polypeptides; genetic engineered cells |
| 07/11/2006 | US7074615 Peptides for enhanced cell attachment and cell growth |
| 07/11/2006 | US7074601 Nucleozymes |
| 07/11/2006 | US7074589 Nucleic acid molecules encoding full length PTP20, PCP-2, BDP1, mCLK2, mCLK3, mCLK4, and SIRP polypeptides, portions of such nucleic acid molecules, nucleic acid vectors containing such nucleic acid molecules, recombinant cells containing such nucleic acid vectors, polypeptides purified from such cells |
| 07/11/2006 | US7074580 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 07/11/2006 | US7074578 identifying transcriptionally active chromatin by contacting chromatin with an antibody that binds to a histone H3 polypeptide which is trimethylated at Lys4, anddetermining the presence or absence of binding of the antibody to the chromatin |
| 07/11/2006 | US7074576 Protein biopolymer markers indicative of alzheimer's disease |
| 07/11/2006 | US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof |
| 07/11/2006 | US7074560 Purification of tissue plasminogen activator (tPA) |
| 07/11/2006 | US7074554 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 07/11/2006 | US7074432 Drug , biocompatible polymer and biphosphonate compound |
| 07/11/2006 | US7074425 Hemostatic compositions and methods |
| 07/11/2006 | US7074415 Polypeptide antigens of streptococcus pneumoniae pathogen which may be useful for prophylaxis, diagnostic or treatment of streptococcal infection |
| 07/11/2006 | US7074412 For therapy of orthopaedic and dental, including periodontal, diseases |
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074409 Polypeptides having a triggering NK activity and biological applications |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074407 immunizing with fragments of CETP (cholesteryl ester transfer protein) which may be conjugated to a carrier, such as KLH (keyhole limpet hemocyanin) or ovalbumin, to increase immunogenicity |
| 07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
| 07/11/2006 | US7074404 Protein purification |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
| 07/11/2006 | US7074401 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 07/11/2006 | US7074399 Treatment of inflammation with p20 |
| 07/11/2006 | US7074397 Method for enhancing proliferation or differentiation of a cell using ob protein |
| 07/11/2006 | US7074388 Water stabilized medicinal aerosol formulation |
| 07/11/2006 | US7074325 Device for concentrating and stabilizing conjugated estrogens from mare urine |
| 07/11/2006 | CA2227984C Aza-anthracyclinone derivatives |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2170754C Injectable compositions for soft tissue augmentation |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/06/2006 | WO2006072113A2 Therapeutic composition |
| 07/06/2006 | WO2006072048A2 Compositions and methods for identifying modulators of hausp |
| 07/06/2006 | WO2006071840A2 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 07/06/2006 | WO2006071822A1 Exotoxin inhibitory factor |
| 07/06/2006 | WO2006071619A1 Compositions for hcv treatment |
| 07/06/2006 | WO2006071618A1 Compounds for flaviviridae treatment |
| 07/06/2006 | WO2006071456A2 Inhibition of hsp27 phosphorylation for treatment of blistering disorders |
| 07/06/2006 | WO2006071451A2 Compounds that prevent macrophage apoptosis and uses thereof |
| 07/06/2006 | WO2006071274A2 Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer’s disease |
| 07/06/2006 | WO2006071208A1 Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
| 07/06/2006 | WO2006070780A1 Par-2 agonist |
| 07/06/2006 | WO2006070742A1 Tolerance development inhibitor for narcotic analgesic agent |
| 07/06/2006 | WO2006070348A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY |
| 07/06/2006 | WO2006070028A1 Pathogenic infection detection compositions and methods |
| 07/06/2006 | WO2006069641A1 Method for producing sterile suspensions or lyophilisates of poorly soluble basic peptide complexes, pharmaceutical formulations containing the same, and use thereof as medicaments |
| 07/06/2006 | WO2006069542A1 Self-assembly luminescent conductive nano-drug crystal and its ultra-thin film and its preparation |
| 07/06/2006 | WO2006069449A1 Chemokine receptor-independent immunomodulatory and anti-proliferative activity |
| 07/06/2006 | WO2006069417A1 A method of treatment |
| 07/06/2006 | WO2006055024A3 Minicells as vaccines |
| 07/06/2006 | WO2006052641A3 Antibody induced cell membrane wounding |
| 07/06/2006 | WO2006046073A3 C1q related protein |
| 07/06/2006 | WO2006044566A9 Autocrine growth factor receptors and methods |
| 07/06/2006 | WO2006044410A3 A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines |
| 07/06/2006 | WO2006043060A3 Mam domain containing protein |
| 07/06/2006 | WO2006043036A3 Treatment of diabetes |
| 07/06/2006 | WO2006043031A3 Class iii slrp for the treatment of cancer |
| 07/06/2006 | WO2006042105A3 Promotion of cell migration and axon regeneration in the cns |
| 07/06/2006 | WO2006031996A3 Targeting viruses using a modified sindbis glycoprotein |